Leomics Associates is a global industry frontrunner, serving organizations throughout the United States, Latin America, Europe and Asia. From our unique perspective, we offer expertise in technology evaluation, transfer and commercialization, filling the gaps in the international market and offering cost effective products that maximize health care quality around the world.

Our customers span all phases of development and commercialization in diagnostics and biotechnology, and include:

Small to medium businesses with emerging technologies:

• Leomics maintains an "up to date" database of the academic and commercial diagnostic, biotechnology and pharmaceutical landscape. This helps us evaluate each small company’s potential, and produce a customized plan.

• We identify breakthrough opportunities for these smaller organizations, and strategize ways to market the results.

• Finally, we guide these organizations through issues such as funding, business plan development, alliance-building, and successful R&D.

Large established businesses with well-established diagnostic, biotechnology, and pharmaceutical capacities:

• Leomics works with these more established entities to strengthen product and technology development, build more effective pipelines, and create new growth business models.

• We work directly with R&D professionals to help them assess potential products and new technologies.

• We critique the current business model, and work with senior management to create alternative business models.

We identify hidden opportunities, balancing R&D portfolios with a combination of high and low risk opportunities that will distinguish the company from its competitors.